Scientists at the Presbyterian-Weill Cornell Medical Center in New York, have discovered a promising experimental treatment for lung cancer.
The treatment involves the use a lung cancer vaccine which exposes the body to the same protein that is produced by lung cancer itself. As with other vaccines, the exposure to the protein prompts the bodies immune system to build defenses against the attacking cancer. This vaccine approach to lung cancer shows how the immune system can be triggered to fight against specific types of cancer.
The vaccine is administered in a series of injections during a two year period. As of late December 2010, researchers were still enrolling new patients. The hospital's phone number is (212) 746-5454.
Hopefully as researchers improve their ability to target specific cancers, this same approach might be used to treat Mesothelioma as well.
The treatment involves the use a lung cancer vaccine which exposes the body to the same protein that is produced by lung cancer itself. As with other vaccines, the exposure to the protein prompts the bodies immune system to build defenses against the attacking cancer. This vaccine approach to lung cancer shows how the immune system can be triggered to fight against specific types of cancer.
The vaccine is administered in a series of injections during a two year period. As of late December 2010, researchers were still enrolling new patients. The hospital's phone number is (212) 746-5454.
Hopefully as researchers improve their ability to target specific cancers, this same approach might be used to treat Mesothelioma as well.
